Sponsor Deadline
Posted: 11/20/2024

Advancing Genomic Medicine Research (R01, R03, R21 Clinical Trial Optional)

This NOFO solicits proposals that stimulate innovation and advance understanding of when, where, and how best to implement the use and sharing of genomic information and technologies in clinical care  provided to all persons irrespective of racial/ethnic background or socioeconomic status. 

This Notice of Funding Opportunity (NOFO) requires a Plan for Enhancing Diverse Perspectives (PEDP).

Although this funding opportunity uses the R01 grant mechanism, it runs in parallel with two program announcements of identical scientific scope, RFA-HG-25-003, which uses the R21 grant mechanism, and RFA-HG-25-004 , which uses the R03 grant mechanism. 

Deadlines:

  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s):  Feb. 11, 2025

RFA-HG-25-002 Expiration Date February 12, 2025
.

Amount Description

Application budgets are limited to $500K d irect costs per year and should reflect the actual needs of the proposed project.

Budgets should include any funds required to support sharing of scientific data under this NOFO. NIH provides guidance on allowable costs for data management and sharing here. For projects generating genomic data derived from research participants, investigators should consider costs associated with complying with the NIH and NHGRI GDS Policy expectations (e.g., obtaining samples with explicit informed consent for future research use and broad data sharing, implementing processes to seek new consent from study participants, etc.). 

Amount
$2,500,000
Funding Type
Eligibility
Posted
11/20/2024
Deadline
Sponsor: